Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TSXV/NRX stock hub

TSXV/NRX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TSXV/NRXis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
52.5M
TSX Venture Exchange
Market data

Live price

Current market quote for this ticker.

Current price
TSXV/NRX
In the news

Latest news · TSXV/NRX

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 11P50 15.6P75 25.4
Trailing P/En/a
P25 7.4P50 15.6P75 34.3
ROE-282.5
P25 -121.5P50 -40.9P75 0.5
ROIC-169.6
P25 -72.5P50 -16P75 1.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TSXV/NRX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
139
Groups with data
11
Currency
USD
Showing 139 of 139 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

16
MetricValue
Country
Canada
Country code
CA
Employees
16
Enterprise value
CAD 49.7M
Exchange
TSX Venture Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Biotechnology
Last refreshed
2026-05-10
Market cap
CAD 52.5M
Price
CAD 0.57
Price currency
CAD
Sector
Healthcare
Sic
2836
Symbol
tsxv/NRX
Website
https://nurexone.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

5
MetricValue
Earnings Yield
-16.68%
EV Earnings
-5.68x
EV/FCF
-7.94x
FCF yield
-11.93%
P/B ratio
13.87x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

5
MetricValue
Net Income
CAD -8.8M
ROA
-121.1
ROCE
-204.4
ROE
-282.5
ROIC
-169.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

2
MetricValue
Cagr1y
-12.32%
Cagr3y
26.73%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Assets
CAD 5.6M
Cash
CAD 2.9M
Current Assets
CAD 3.6M
Current Liabilities
CAD 1.4M
Debt
CAD 148,081
Debt Equity
CAD 0.04
Debt FCF
CAD -0.02
Equity
CAD 3.8M
Interest Coverage
-204
Liabilities
CAD 1.8M
Long Term Assets
CAD 2M
Long Term Liabilities
CAD 464,722
Net Cash
CAD 2.8M
Net Cash By Market Cap
CAD 5.31
Net Cash Growth
204.35%
Net Debt Equity
CAD -0.74
Tangible Book Value
CAD 3.8M
Tangible Book Value Per Share
CAD 0.04
WACC
6.04

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
2.63
Net Working Capital
CAD -669,107
Quick ratio
2.25
Working Capital
CAD 2.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-22.32%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
1Y total return
-12.31%
200-day SMA
0.72
3Y total return
103.57%
50-day SMA
0.62
50-day SMA vs 200-day SMA
50under200
All Time High
1.19
All Time High Change
-52.1%
All Time High Date
2024-02-20
All Time Low
0.1
All Time Low Change
470%
All Time Low Date
2023-04-14
ATR
0.03
Beta
0.32
Beta1y
0.06
Beta2y
-0
Ch YTD
-13.64
High
0.58
High52
1.14
High52 Date
2025-09-16
High52ch
-50%
Low
0.57
Low52
0.54
Low52 Date
2026-05-07
Low52ch
5.56%
Ma50ch
-7.65%
Price vs 200-day SMA
-20.91%
RSI
44.54
RSI Monthly
45.39
RSI Weekly
40.09
Sharpe ratio
-0.02x
Sortino ratio
0.08
Total Return
-22.32%
Tr YTD
-13.64
Tr1m
-14.93%
Tr3m
-16.18%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

1
MetricValue
Operating Income
CAD -8.7M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
87,372,574%
Net Borrowing
-30,075.1
Shares Insiders
5.08%
Shares Out
92,045,848
Shares Qo Q
12.5%
Shares Yo Y
22.32%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

45
MetricValue
Adjusted FCF
CAD -8M
Average Volume
20,268.75x
Bv Per Share
0.04
CAPEX
CAD -75,412
Ch1m
-14.93
Ch1y
-12.31
Ch3m
-16.18
Ch3y
103.6
Ch6m
-18.57
Change
1.79%
Change From Open
-1.72
Close
0.56
Days Gap
3.57
Depreciation Amortization
213,259.8
Dollar Volume
13,680
Earnings Date
2026-05-28
EBIT
CAD -8.7M
EBITDA
CAD -8.5M
EPS
CAD -0.11
F Score
1
FCF
CAD -6.3M
FCF EV Yield
-12.6x
FCF Per Share
CAD -0.07
Financing CF
7,999,114
Fiscal Year End
December
Founded
2,020
Investing CF
-75,412
Is Primary Listing
1
Last Earnings Date
2025-11-28
Last Report Date
2025-12-31
Ma150
0.69
Ma150ch
-17.26%
Ma20
0.61
Ma20ch
-6.02%
Net CF
1,971,671
Next Earnings Date
2026-05-28
Open
0.58
Position In Range
0
Ppne
1,181,131.2
Price Date
2026-05-08
Ptbv Ratio
13.87
Relative Volume
1.18x
Share Based Comp
1,768,745
Tr6m
-18.57%
Volume
24,000
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does TSXV/NRX pay a dividend?

Capital-return profile for this ticker.

Performance

TSXV/NRX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-12.3%
S&P 500 1Y: n/a
3Y total return
+103.6%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns TSXV/NRX?

Insider, institutional, and short-interest positioning.

Institutional ownership
n/a
Share of float held by funds and institutions
Insider ownership
+5.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+22.3%
Negative means the company is buying back shares.
Technical

TSXV/NRX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
44.5
Neutral momentum band
Price vs 200-day MA
-20.9%
50/200-day relationship not available
Beta (5Y)
0.32
Less volatile than the market
Sharpe ratio
-0.02
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TSXV/NRX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsxv/NRX stock rating?

tsxv/NRX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsxv/NRX analysis?

The full report lives at /stocks/tsxv/NRX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsxv/NRX?

The latest report frames tsxv/NRX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsxv/NRX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.